AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Novonesis AS

Director's Dealing Feb 15, 2012

Preview not available for this file type.

Download Source File

February 15, 2012

In accordance with Section 28a of the Danish Securities Trading Act, Novozymes
reports
the following transactions under ISIN DK0060336014, Novozymes B shares under the
symbol NZYM B.

Name: Per Falholt

Relation/: EVP, and CSO
Category of
close relation

Trading date: 15/2/2012

Character of: Exercise of Options (purchase of shares)
transaction

Volume of : +64,900
transaction
Buy (+) /
Sell (-)

Value: 5,062,000
of trans-
action (DKK)

Contact persons:
Press and media: Investor relations:
René Tronborg (Europe)
Tel. (direct): +45 4446 2274
Tel. (mobile): +45 3077 2274

Paige Donnelly (USA)
Tel. (direct): +1 919 494 3209
Tel. (mobile): +1 919 218 4501 Martin Riise
Tel. (direct): +45 4446 0738
Tel. (mobile): +45 3077 0738

Thomas Bomhoff (USA)
Tel. (direct): +1 919 494 3483
Tel. (mobile): +1 919 649 2565

Novozymes is the world leader in bioinnovation. Together with customers across
a broad array of industries we create tomorrow’s industrial biosolutions,
improving our customers’ business and the use of our planet’s resources. Read
more at www.novozymes.com.

Talk to a Data Expert

Have a question? We'll get back to you promptly.